• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Nearly 20 states sue HHS over declaration to restrict gender transition treatment for minors

by December 25, 2025
written by December 25, 2025

A group of 19 Democrat-led states and Washington, D.C., filed a lawsuit against the Trump administration over a declaration that aims to restrict gender transition treatment for minors.

The lawsuit against the U.S. Department of Health and Human Services; its secretary, Robert F. Kennedy Jr.; and its inspector general comes after the declaration issued last week described treatments such as puberty blockers, hormone therapy and gender surgeries as unsafe and ineffective for children experiencing gender dysphoria.

The declaration also warned doctors they could be excluded from federal health programs, including Medicare and Medicaid, if they provide these treatments to minors.

The move seeks to build on President Donald Trump’s executive order in January calling on HHS to protect children from ‘chemical and surgical mutilation.’

‘We are taking six decisive actions guided by gold standard science and the week one executive order from President Trump to protect children from chemical and surgical mutilation,’ Kennedy said during a press conference last week.

HHS has also proposed new rules designed to further block gender transition treatment for minors, although the lawsuit does not address the rules, which have yet to be finalized.

The states’ lawsuit, filed Tuesday in Eugene, Oregon, argues that the declaration is inaccurate and unlawful and urges the court to prevent it from being enforced.

‘Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices,’ New York Attorney General Letitia James, who led the lawsuit, said in a statement.

The lawsuit claims the declaration attempts to pressure providers into ending gender transition treatment for young people and circumvent legal requirements for policy changes. The complaint said federal law requires the public be given notice and an opportunity to comment before substantively amending health policy and that neither of these were done before the declaration was released.

The declaration based its conclusions on a peer-reviewed report that the department conducted earlier this year that called for more reliance on behavioral therapy rather than broad gender transition treatment for minors with gender dysphoria.

The report raised questions about standards for the treatment of transgender children issued by the World Professional Association for Transgender Health and brought concerns that youths may be too young to give consent to life-changing treatments that could result in future infertility.

Major medical groups and physicians who treat transgender children have criticized the report as inaccurate.

HHS also announced last week two proposed federal rules — one to cut off federal Medicaid and Medicare funding from hospitals that offer gender transition treatment to children and another to block federal Medicaid money from being used for these procedures.

The proposals have not yet been made final and are not legally binding because they must go through a lengthy rulemaking process and public comment before they can be enforced.

Several major medical providers have already pulled back on gender transition treatment for youths since Trump returned to office, even those in Democrat-led states where the procedures are legal under state law.

Medicaid programs in just under half of states currently cover gender transition treatment. At least 27 states have adopted laws restricting or banning the treatment, and the Supreme Court’s decision this year upholding Tennessee’s ban likely means other state laws will remain in place.

Democrat attorneys general from California, Colorado, Connecticut, Delaware, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Jersey, New Mexico, Oregon, Rhode Island, Vermont, Wisconsin, Washington state and Washington, D.C., as well as Pennsylvania’s Democrat governor, joined James in the lawsuit.

The Associated Press contributed to this report.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump-backed candidate Asfura wins Honduras presidential election
next post
Christmas Eve jazz concert canceled at Kennedy Center after Trump name added to building

related articles

Chloe Cole Act aimed at blocking minors from...

February 23, 2026

Rep Randy Fine to bring 4-legged guest Sadie...

February 23, 2026

Trump’s ‘total elimination’ strategy paved way for fall...

February 23, 2026

Iran president vows defiance as protests build against...

February 23, 2026

Trump’s science and tech man lays out White...

February 23, 2026

Family of Iowa grad killed by illegal immigrant...

February 23, 2026

Trump, Schumer find rare common ground on releasing...

February 23, 2026

Trump envoy rebukes Greenland leader for rejecting hospital...

February 23, 2026

State Dept orders evacuation of non-emergency US personnel...

February 23, 2026

Federal judge blocks release of Jack Smith report’s...

February 23, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Pastor Max Lucado: Surviving a challenging election season is possible

    August 11, 2024
  • Former FBI Director Robert Mueller has Parkinson’s disease: report

    September 1, 2025
  • From Caracas to Chicago: Trump’s Article II powers face their biggest tests yet

    January 19, 2026
  • Long ACN: strong bullish momentum backed by strategic acquisition and AI-driven revenue growth prospects

    July 23, 2024
  • Drone incursions on US bases come under intense scrutiny as devices prove lethality overseas

    June 26, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,043)
  • Investing (1,049)
  • Stock (979)

Latest Posts

  • Comey indicted for alleged false statements, obstruction of congressional proceeding

    September 26, 2025
  • GOGL Stock Price Today: Up by 1.21% and Rising

    July 17, 2024
  • Republicans light cigars, cigarettes on burning photos of Khamenei to show support for Iranian protesters

    January 14, 2026

Recent Posts

  • Trump eyes an end to new windmill production under second term, says they are ‘driving the whales crazy’

    January 8, 2025
  • Eli Lilly’s $123 billion market value drop: A strategic buying opportunity?

    July 30, 2024
  • Trump to address House GOP in his own backyard during Miami working retreat

    January 27, 2025

Editor’s Pick

  • Amazon set to pass Walmart in revenue for first time

    February 6, 2025
  • Pro-life groups sound off after Trump says he will not restrict abortion pills: ‘Serious and growing threat’

    December 9, 2024
  • Long AER: AerCap Defends Key Support at $100, Bullish Momentum Builds After Strong Earnings Beat

    March 3, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock